{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T17:22:36Z","timestamp":1775064156599,"version":"3.50.1"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Epidemiology"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.canep.2025.102896","type":"journal-article","created":{"date-parts":[[2025,7,26]],"date-time":"2025-07-26T09:13:36Z","timestamp":1753521216000},"page":"102896","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Interleukin gene polymorphisms (IL1B, IL6, IL10, IL16, IL28B) increase prostate cancer risk and associate with aggressive disease features in Iraqi men: A case-control study"],"prefix":"10.1016","volume":"98","author":[{"given":"Wisam Hindawi","family":"Hoidy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2751-862X","authenticated-orcid":false,"given":"Mohammed Hamza","family":"Al-Saadi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3100-2896","authenticated-orcid":false,"given":"Simon","family":"Clegg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.canep.2025.102896_bib1","article-title":"Prevalence and associated risk factors of prostate cancer among a large Chinese population","volume":"14","author":"Chen","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.canep.2025.102896_bib2","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.ijsu.2018.02.050","article-title":"Viral etiology of prostate cancer: genetic alterations and immune response. A literature review","volume":"52","author":"Abidi","year":"2018","journal-title":"Int. J. Surg."},{"key":"10.1016\/j.canep.2025.102896_bib3","doi-asserted-by":"crossref","first-page":"312","DOI":"10.20517\/jtgg.2024.52","article-title":"Risk factors influencing chronic inflammation in neoplastic transition to prostate cancer","volume":"8","author":"Prakash","year":"2024","journal-title":"J. Transl. Genet. Genom."},{"key":"10.1016\/j.canep.2025.102896_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.115015","article-title":"Evaluation of the association of chronic inflammation and cancer: insights and implications","volume":"164","author":"Nigam","year":"2023","journal-title":"Biomed. Pharm."},{"key":"10.1016\/j.canep.2025.102896_bib5","doi-asserted-by":"crossref","first-page":"S34","DOI":"10.1002\/eji.200737772","article-title":"Historical insights into cytokines","volume":"37","author":"Dinarello","year":"2007","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.canep.2025.102896_bib6","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1186\/s43042-022-00324-7","article-title":"Polymorphism of the IL-10 gene in Azeri population of Iran","volume":"23","author":"Asgharzadeh","year":"2022","journal-title":"Egypt. J. Med. Hum. Genet"},{"key":"10.1016\/j.canep.2025.102896_bib7","doi-asserted-by":"crossref","first-page":"13501","DOI":"10.3390\/ijms252413501","article-title":"Systematic review of IL-1, IL-4, IL-6, IL-10, IL-15, and IL-18 gene polymorphisms and meta-analysis of IL-6 variant and its association with overweight and obesity risk in men","volume":"25","author":"Bojarczuk","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.canep.2025.102896_bib8","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.3390\/cancers12071791","article-title":"Interleukin-1\u03b2 and Cancer","volume":"12","author":"R\u00e9b\u00e9","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.canep.2025.102896_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fmed.2024.1307394","article-title":"Exploring the role of IL-1\u03b2 in inflammatory bowel disease pathogenesis","volume":"11","author":"Aggeletopoulou","year":"2024","journal-title":"Front. Med."},{"key":"10.1016\/j.canep.2025.102896_bib10","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.1023177","article-title":"The role of IL-6\/JAK2\/STAT3 signaling pathway in cancers","volume":"12","author":"Huang","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.canep.2025.102896_bib11","article-title":"Meta-analysis of the role of IL-6 rs1800795 polymorphism in the susceptibility to prostate cancer Evidence based on 17 studies","volume":"96","author":"Liu","year":"2017","journal-title":"Medicine"},{"key":"10.1016\/j.canep.2025.102896_bib12","article-title":"Association of interleukin-6 genetic polymorphisms (rs1800795, -174C > G and rs1800796, -572G > C) with risk of essential hypertension in the chinese population","volume":"15","author":"Ren","year":"2023","journal-title":"Cureus"},{"key":"10.1016\/j.canep.2025.102896_bib13","article-title":"The interplay between cytokines, inflammation, and antioxidants: mechanistic insights and therapeutic potentials of various antioxidants and anti-cytokine compounds","volume":"178","author":"Bho","year":"2024","journal-title":"Biomed. Pharm."},{"key":"10.1016\/j.canep.2025.102896_bib14","doi-asserted-by":"crossref","DOI":"10.1177\/0300060520904863","article-title":"Association of interleukin 10 rs1800896 polymorphism with susceptibility to breast cancer: a meta-analysis","volume":"48","author":"Zhu","year":"2020","journal-title":"J. Int. Med. Res."},{"key":"10.1016\/j.canep.2025.102896_bib15","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1093\/carcin\/bgn281","article-title":"The association of interleukin-16 polymorphisms with IL-16 serum levels and risk of colorectal and gastric cancer","volume":"30","author":"Gao","year":"2009","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.canep.2025.102896_bib16","doi-asserted-by":"crossref","first-page":"135","DOI":"10.3390\/life15020135","article-title":"Genetic variants of interleukin-8 and interleukin-16 and their association with cervical cancer risk","volume":"15","author":"Watrowski","year":"2025","journal-title":"Life"},{"key":"10.1016\/j.canep.2025.102896_bib17","doi-asserted-by":"crossref","first-page":"230","DOI":"10.3390\/tropicalmed7090230","article-title":"Interleukin 28B polymorphism as a predictor of sustained virological response to sofosbuvir-based therapy for hepatitis C virus patients","volume":"7","author":"Zaki","year":"2022","journal-title":"Trop. Med. Infect. Dis."},{"key":"10.1016\/j.canep.2025.102896_bib18","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1038\/nature08463","article-title":"Genetic variation in IL28B and spontaneous clearance of hepatitis C virus","volume":"461","author":"Thomas","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.canep.2025.102896_bib19","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1038\/pcan.2011.6","article-title":"IL-10 polymorphisms and prostate cancer risk: a meta-analysis","volume":"14","author":"Shao","year":"2011","journal-title":"Prostate Cancer Prostatic Dis."},{"key":"10.1016\/j.canep.2025.102896_bib20","doi-asserted-by":"crossref","first-page":"287","DOI":"10.31557\/APJCP.2024.25.1.287","article-title":"Correlation between rs1800871, rs1800872 and rs1800896 polymorphisms at IL-10 gene and lung cancer risk","volume":"25","author":"Vakili","year":"2023","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"10.1016\/j.canep.2025.102896_bib21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2022\/3915402","article-title":"Association between XRCC3 rs861539 polymorphism and the risk of ovarian cancer: meta-analysis and trial sequential analysis","volume":"2022","author":"Hu","year":"2022","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.canep.2025.102896_bib22","doi-asserted-by":"crossref","first-page":"3283","DOI":"10.31557\/APJCP.2023.24.9.3283","article-title":"M.H. Al-Saadi, Development of a T-ARMS-PCR assay for detecting genetic polymorphism in the catalase (rs7943316) gene in the iraqi population with breast cancer","volume":"24","author":"Hoidy","year":"2023","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"10.1016\/j.canep.2025.102896_bib23","first-page":"1","article-title":"Association of IL-1\u03b2 (C+3954T) and IL-10 (C-819T) polymorphisms with cytokine production in health and disease","volume":"169","author":"Langmia","year":"2016","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.canep.2025.102896_bib24","first-page":"88","article-title":"M. Shakeri, Association of IL-1\u03b2 C-511T gene polymorphism with risk of osteoarthritis: a case-control study","volume":"15","author":"Naderi","year":"2022","journal-title":"BMC Med. Genom."},{"key":"10.1016\/j.canep.2025.102896_bib25","first-page":"481","article-title":"Interleukin-1\u03b2 -511C>T polymorphism and the risk of Alzheimer's disease: an updated meta-analysis","volume":"42","author":"Ren","year":"2021","journal-title":"Neurol. Sci."},{"key":"10.1016\/j.canep.2025.102896_bib26","first-page":"1207","article-title":"Association between the IL-1\u03b2 C-511T polymorphism and inflammatory markers in patients with chronic periodontitis: a systematic review and meta-analysis","volume":"14","author":"Teixeira","year":"2021","journal-title":"J. Inflamm. Res"},{"key":"10.1016\/j.canep.2025.102896_bib27","first-page":"12247","article-title":"Association of interleukin-6\u2013174\u202fG>C gene polymorphism with risk of prostate cancer: a systematic review and meta-analysis","volume":"12","author":"Khamees","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.canep.2025.102896_bib28","first-page":"15","article-title":"Recent insights into NF-\u03baB signalling pathways and the link between inflammation and prostate cancer","volume":"127","author":"Nguyen","year":"2021","journal-title":"BJU Int"},{"key":"10.1016\/j.canep.2025.102896_bib29","article-title":"Association of IL-10 gene promoter polymorphisms with susceptibility to prostate cancer: evidence from an updated meta-analysis","volume":"12","author":"Yuan","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.canep.2025.102896_bib30","article-title":"The IL-10\/STAT3 axis is involved in tumor immune evasion: a comprehensive analysis of human breast and prostate cancers","volume":"13","author":"Zhu","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.canep.2025.102896_bib31","first-page":"338","article-title":"Y. Zhang, Association between interleukin-16 polymorphisms and risk of coronary artery disease","volume":"40","author":"Wu","year":"2021","journal-title":"DNA Cell Biol."},{"key":"10.1016\/j.canep.2025.102896_bib32","article-title":"L. Zhao, The regulatory role of IL-16 gene polymorphisms in the pathogenesis of prostate cancer and benign prostatic hyperplasia","volume":"101","author":"Li","year":"2022","journal-title":"Medicine"},{"key":"10.1016\/j.canep.2025.102896_bib33","article-title":"IL28B rs12979860 polymorphism influences the susceptibility to hepatocellular carcinoma in hepatitis B virus-infected patients","volume":"9","author":"Gong","year":"2021","journal-title":"Mol. Genet. Genom. Med."},{"key":"10.1016\/j.canep.2025.102896_bib34","doi-asserted-by":"crossref","first-page":"3839","DOI":"10.31557\/APJCP.2019.20.12.3839","article-title":"Association of CYP1A1 rs1048943 polymorphism with prostate cancer in iraqi men patients","volume":"20","author":"Hoidy","year":"2019","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"10.1016\/j.canep.2025.102896_bib35","first-page":"145","article-title":"Cytokine gene polymorphisms in Iraqi cancer patients: A comprehensive analysis","volume":"20","author":"Al-Saadi","year":"2022","journal-title":"Iraqi J. Med. Sci."},{"key":"10.1016\/j.canep.2025.102896_bib36","first-page":"156","article-title":"Interleukin-10 gene polymorphisms and cancer risk in Iranian population: a case-control study","volume":"162","author":"Tolue","year":"2023","journal-title":"Cytokine"},{"key":"10.1016\/j.canep.2025.102896_bib37","first-page":"2341","article-title":"Association of IL-6\u2013174\u202fG\/C polymorphism with cancer susceptibility in Turkish population","volume":"50","author":"Hemmati","year":"2023","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.canep.2025.102896_bib38","first-page":"445","article-title":"IL-6 polymorphisms and cancer risk: a meta-analysis in Caucasian populations","volume":"28","author":"Yazdani","year":"2019","journal-title":"Eur. J. Cancer Prev."},{"key":"10.1016\/j.canep.2025.102896_bib39","first-page":"234","article-title":"Cumulative genetic risk assessment through haplotype analysis in cancer susceptibility","volume":"116","author":"Allahverdi","year":"2024","journal-title":"Genomics"}],"container-title":["Cancer Epidemiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1877782125001560?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1877782125001560?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T03:28:31Z","timestamp":1765337311000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1877782125001560"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":39,"alternative-id":["S1877782125001560"],"URL":"https:\/\/doi.org\/10.1016\/j.canep.2025.102896","relation":{},"ISSN":["1877-7821"],"issn-type":[{"value":"1877-7821","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Interleukin gene polymorphisms (IL1B, IL6, IL10, IL16, IL28B) increase prostate cancer risk and associate with aggressive disease features in Iraqi men: A case-control study","name":"articletitle","label":"Article Title"},{"value":"Cancer Epidemiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canep.2025.102896","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102896"}}